Common Stock, Shares, Issued of China SXT Pharmaceuticals, Inc. from 20 Oct 2017 to 31 Mar 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
China SXT Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 20 Oct 2017 to 31 Mar 2025.
  • China SXT Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending 31 Mar 2025 was 13,763,268, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

China SXT Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 13,763,268 0 0% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q3 2024 3,906,471 +3,178,620 +437% 30 Sep 2024 6-K 28 Mar 2025 2025 Q2
Q1 2024 13,763,268 +13,305,903 +2909% 31 Mar 2024 20-F 31 Jul 2025 2025 FY
Q3 2023 727,851 -2,885,034 -80% 30 Sep 2023 6-K 05 Apr 2024 2024 Q2
Q1 2023 457,365 -1,574,029 -77% 31 Mar 2023 20-F 13 Aug 2024 2024 FY
Q3 2022 3,612,885 -13,257,353 -79% 30 Sep 2022 6-K 24 Feb 2023 2023 Q2
Q2 2022 128,750 17 May 2022 20-F/A 19 May 2023 2022 FY
Q1 2022 2,031,394 +1,255,139 +162% 31 Mar 2022 20-F 31 Jul 2023 2023 FY
Q3 2021 16,870,238 -47,187,346 -74% 30 Sep 2021 6-K 14 Jan 2022 2022 Q2
Q1 2021 776,255 -8,890,673 -92% 31 Mar 2021 20-F/A 19 May 2023 2022 FY
Q3 2020 64,057,584 +36,832,718 +135% 30 Sep 2020 6-K 28 Jan 2021 2021 Q2
Q1 2020 9,666,928 -13,039,773 -57% 31 Mar 2020 20-F 13 Aug 2021 2021 FY
Q3 2019 27,224,866 30 Sep 2019 6-K/A 22 May 2020 2020 Q2
Q1 2019 22,706,701 +2,706,701 +14% 31 Mar 2019 20-F 31 Jul 2020 2020 FY
Q1 2018 20,000,000 31 Mar 2018 20-F 15 Aug 2019 2019 FY
Q3 2017 9,700,000 20 Oct 2017 6-K 05 Apr 2024 2024 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.